She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
The combination will support clients in getting their end-to-end discovery and development programs delivered.
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Subscribe To Our Newsletter & Stay Updated
